NCT00002792
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +23 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Thrombocytosis
Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.
177 public trials
30 recruiting studies
Thrombocytosis trial results
NCT00005804
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Active, Not Recruiting
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
- Washington University School of Medicine - Division of Oncology St Louis, Missouri, United States
- MD Anderson Cancer Center Houston, Texas, United States
- University of Utah Salt Lake City, Utah, United States
Active, Not Recruiting
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
NCT06079879
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) Glendale, Arizona, United States
- Los Angeles Cancer Network ( Site 3491) Glendale, California, United States
- Stanford Cancer Institute ( Site 0107) Stanford, California, United States
- The Lundquist Institute ( Site 3423) Torrance, California, United States
Active, Not Recruiting
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
- Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
- Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
- Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
Active, Not Recruiting
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
NCT03289910
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
NCT00544115
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +95 more
- Locations
-
Not specified
Active, Not Recruiting
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
NCT04279847
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +19 more
- Locations
-
- University of Alabama At Birmingham Birmingham, Alabama, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Emory University-Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States